Biotech Values

[drbio45]

medicure mc-1

If this phase III succeeds (which i doubt it), I'll make a $5 wager with you that approved MC-1 goes the way of BiDil.

In the meantime, I'll keep quiet on this topic.



The above comment you made shows the bias you have in this instance. You can doubt the the trial succeeds although the data from the prior trial seems to make chances of success better than in most cases. In fact the fda even thinks so because they allowed the data from the phase 2 trial to be used as a pivotal trial. They don't usually do that.

To say that the drug would go the way of bidil is a misconception on your part. The failure of Bidil was more a function of the drug being targeted to African Americans than the problem it had with generic alternatives which can be shown by looking at the fact that even people with medicaid. They aren't getting Bidil prescriptions filled even though they pay nothing for them. They would not care about generic alternatives.

As I believe Daved previously posted, a hospital that prescribes generic P5P or vitamin b-6 to the first person that dies after the surgery would be sued for not prescribing the FDA approved drug from its hospital formulary.

by the way there are articles that have been posted In the New England Journal of Medicine which makes it clear that B-6 does not work in the indication.

You can continue to be biased if you like. The stock will either sit here or go up without your ownership